Abstract
In Finland a collaborative effort by Helsinki University Central Hospital, MAP Medical Technologies Inc. and VTT Reactor Laboratory has started aiming at BNCT of glioma patients. For this the capabilities of the FiR-1 TRIGA II 250 kW research reactor have been evaluated.
| Original language | English |
|---|---|
| Title of host publication | Advances in Neutron Capture Therapy |
| Subtitle of host publication | Proceedings of the 5th International Symposium on Neutron Capture Therapy |
| Editors | Albert H. Soloway, Rolf F. Barth, David E. Carpenter |
| Place of Publication | New York |
| Publisher | Plenum |
| Pages | 81-84 |
| ISBN (Electronic) | 978-1-4615-2978-1 |
| ISBN (Print) | 978-1-4613-6296-8 |
| DOIs | |
| Publication status | Published - 1993 |
| MoE publication type | A4 Article in a conference publication |
| Event | 5th International Symposium on Neutron Capture Therapy - Columbus, United States Duration: 14 Sept 1992 → 17 Sept 1992 |
Conference
| Conference | 5th International Symposium on Neutron Capture Therapy |
|---|---|
| Country/Territory | United States |
| City | Columbus |
| Period | 14/09/92 → 17/09/92 |
Fingerprint
Dive into the research topics of 'Epithermal BNCT neutron beam design for a Triga II reactor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver